Apollo Management Holdings adds Chemours Co (CC) to its portfolio

Chemours Co (CC) : Apollo Management Holdings added new position in Chemours Co during the most recent quarter end. The investment management firm now holds 110,700 shares of Chemours Co which is valued at $1.1 Million , the company said in a statement filed on May 12, 2016 with the SEC.Chemours Co makes up approximately 0.04% of Apollo Management Holdings’s portfolio.

Other Hedge Funds, Including , Brave Asset Management Inc reduced its stake in CC by selling 1,000 shares or 17.69% in the most recent quarter. The Hedge Fund company now holds 4,654 shares of CC which is valued at $45,656. Chemours Co makes up approx 0.03% of Brave Asset Management Inc’s portfolio.Thompson Siegel Walmsley reduced its stake in CC by selling 700 shares or 90.91% in the most recent quarter. The Hedge Fund company now holds 70 shares of CC which is valued at $687. Diam Ltd. sold out all of its stake in CC during the most recent quarter. The investment firm sold 26,001 shares of CC which is valued $266,770. Parkside Financial Bank Trust added CC to its portfolio by purchasing 275 company shares during the most recent quarter which is valued at $2,822.Whitnell reduced its stake in CC by selling 180 shares or 18.65% in the most recent quarter. The Hedge Fund company now holds 785 shares of CC which is valued at $7,159.

Chemours Co closed down -0.28 points or -2.73% at $9.97 with 36,71,224 shares getting traded on Friday. Post opening the session at $10.29, the shares hit an intraday low of $9.5 and an intraday high of $10.5 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Chemours Co reported $0.06 EPS for the quarter, based on the information available during the earnings call on May 2, 2016. Analyst had a consensus estimate of $0.06. The company had revenue of $1297.00 million for the quarter, compared to analysts expectations of $1267.06 million. The company’s revenue was down -4.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.33 EPS.

Many Wall Street Analysts have commented on Chemours Co. Company shares were Reiterated by Barclays on May 9, 2016 to “Overweight”, Firm has raised the Price Target to $ 15 from a previous price target of $14 .Chemours Co was Upgraded by Goldman to ” Buy” on Mar 14, 2016. Chemours Co was Downgraded by Jefferies to ” Hold” on Feb 16, 2016.

The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.

Leave a Reply

Chemours Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemours Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.